Article
Coagulation activation-induced fibrinolysis biomarker changes depend on thrombophilic risk factors and their clinical phenotype: an interventional <i>in vivo</i> study
2023-11-26
Abstract excerpt
<h4>Background</h4> Recently we have shown alterations in the anticoagulant response to recombinant activated factor VII (rFVIIa)-induced coagulation activation in patients with thrombophilia. <h4>Objectives</h4> Here we extended this in vivo model to study fibrinolysis biomarkers. <h4>Methods</h4> The study population included 56 patients with thrombophilia and a history of venous thromboembolism (VTE+), 38...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 857eaa93-5e94-5fe1-866e-8813e0111aeb
- DOI
- 10.1101/2023.11.26.568725
